PDPN and meningioma: Besides podoplanin, somatostatin receptors, especially somatostatin receptor 2 (SSTR-2) and somatostatin receptor 5 (SSTR-5), are frequently expressed in meningiomas and are promising targets for malignant meningioma [122,123,124].